1. Aronson K.J., Miller A.B., Woolcott C.G., Sterns E.E., McCReady D.R., Lickley L.A., Fish E.B., Hiraki G.Y., Holloway C., Ross T., Hanna W.M., SenGupta S.K., and Weber J.P. Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2000: 9: 55–63.
2. Band P.R., Le N.D., Fang R., Threlfall W.J., and Gallagher R.P. Identification of occupational cancer risks in British Columbia: Part II: A population-based case-control study of 1516 prostatic cancer cases. J Occup Environ Med 1999: 41 (4): 233–247.
3. Baris D., Kwak L.W., Rothman N., Wilson W., Manns A., Tarone R.E., and Hartge P. Blood levels of organochlorines before and after chemotherapy among non-Hodgkin's lymphoma patients. Cancer Epidemiol Biomarkers Prevent 2000: 9: 193–197.
4. Bostwick D.G., Burke H.B., Djakiew D, Euling S, Ho S.M, Landolph J, Morrison H, Sonawane B, Shifflett T, Waters D.J and Timm S . Human prostate cancer risk factors. Cancer 2004: 101 (10 Suppl): 2371–2490
5. Carter B.S., Bova G.S., Beaty T.H., Steinberg G.D., Childs B., Isaacs W., and Walsh P.C. Hereditary prostate cancer: epidemiologic and clinical features. J Urol 1993: 150: 797–802.